Arden Trust CO Bei Gene, Ltd. Transaction History

Arden Trust CO

  • $683 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 15, 2021
SELL
$221.31 - $316.61 $193,424 - $276,717
-874 Closed
0 $0
Q3 2020

Oct 15, 2020
BUY
$189.18 - $286.44 $165,343 - $250,348
874 New
874 $250,000
Q2 2020

Jul 09, 2020
SELL
$123.9 - $195.41 $116,961 - $184,467
-944 Closed
0 $0
Q1 2020

Apr 16, 2020
BUY
$121.84 - $173.19 $115,016 - $163,491
944 New
944 $117,000

Others Institutions Holding BGNE

# of Institutions
250
Shares Held
45.3M
Call Options Held
292K
Put Options Held
119K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $20.2B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Arden Trust CO Portfolio

Follow Arden Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email